Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Times Interest Earned (2022 - 2026)

Elicio Therapeutics filings provide 2 years of Times Interest Earned readings, the most recent being -$4696.0 for Q4 2023.

  • On a quarterly basis, Times Interest Earned fell 7147.64% to -$4696.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$33.75, a 132.7% decrease, with the full-year FY2025 number at -$33.29, up 66.33% from a year prior.
  • Times Interest Earned hit -$4696.0 in Q4 2023 for Elicio Therapeutics, up from -$10771.0 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$5.35 in Q3 2022 to a low of -$10771.0 in Q3 2023.